A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations	Advanced Solid Tumors; KRAS G12D Mutations	Recruiting	Phase 1 / Phase 2	2025-11-20		NCT06500676

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Genfleet Therapeutics (Shanghai) Inc.	11

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer hospital, Chinese Academy of Medical Sciences	Beijing	China	12
Guangxi Medical University Cancer Hospital	Nanning	China	24
Harbin Medical University Cancer Hospital	Haerbin	China	3
Hunan Cancer Hospital	Changsha	China	87
Jiangsu Province Hospital	Nanjing	China	37
Liaoning Cancer Hospital & Institute	Shenyang	China	14
Peking Union Medical College Hospital	Beijing	China	48
Shandong Cancer Hospital	Jinan	China	31
Shanghai Chest Hospital	Shanhai	China	1
Sichuan Cancer Hospital	Chengdu	China	30
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	34
The First Affiliated Hospital of Anhui Medical University	Hefei	China	44
The First Affiliated Hospital of China Medical University	Shenyang	China	12
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
The First Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	8
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	22
The Sixth Affiliated Hospital of Sun Yat-sen University	Guangzhou	China	9
Tianjin Medical University Cancer Institute & Hospital	Tianjing	China	1
Union Hospital Tongji Medical College Huazhong University Of Science And Technology	Wuhan	China	18
Zhejiang Cancer Hospital	Hangzhou	China	84

Clinical trials